Dexmedetomidine and Delirium in Patients After Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

November 30, 2015

Conditions
DeliriumC.Surgical Procedure; CardiacPostoperative Complications
Interventions
DRUG

dexmedetomidine hydrochloride for injection

"Before anesthesia, dexmedetomidine hydrochloride for injection (200 ug/2 ml) will be diluted with normal saline to 50 ml (final dexmedetomidine concentration 4 ug/ml).~Before the induction of anesthesia, a loading dose will be administered by intravenous infusion at a rate of \[0.9\*kg\] ml/h for 10 minutes (i.e., dexmedetomidine 0.6 μg/kg in 10 minutes), followed by continuous infusion at a rate of \[0.1\*kg\] ml/h (i.e., dexmedetomidine at a rate of 0.4 μg /kg/h) until the end of surgery.~At the end of surgery, the infusion rate will be decreased to \[0.025\*kg\] ml/h (i.e., dexmedetomidine at a rate of 0.1 ug/kg/h) and continued until the end of mechanical ventilation after surgery."

DRUG

0.9% sodium chloride for injection

"Before anesthesia, 0.9% sodium chloride for injection 50 ml will be prepared.~Before the induction of anesthesia, a loading dose will be administered by intravenous infusion at a rate of \[0.9\*kg\] ml/h for 10 minutes, followed by continuous infusion at a rate of \[0.1\*kg\] ml/h until the end of surgery.~At the end of surgery, the infusion rate will be decreased to \[0.025\*kg\] ml/h and continued until the end of mechanical ventilation after surgery."

Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors
collaborator

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

lead

Peking University First Hospital

OTHER

NCT02267538 - Dexmedetomidine and Delirium in Patients After Cardiac Surgery | Biotech Hunter | Biotech Hunter